Loading company…
Xsensio develops a wearable sensing platform for continuous monitoring of health biomarkers.
Xsensio develops the Lab-on-Skin™ platform for continuous monitoring of biomarkers in settings such as intensive care, outpatient care and the home. Founded in 2014 and based in Lausanne, Switzerland, it raised USD 7 million in Series A funding in March 2026, led by WI Harper Group with participation from Privilege Ventures and European Innovation Council.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in